1991
DOI: 10.1016/s0957-4166(00)82165-5
|View full text |Cite
|
Sign up to set email alerts
|

An asymmetric synthesis of (R)-(+)-2-nonyl-2-(carbomethoxy) cyclopentanone, a known precursor of the antibiotic (−)-malyngolide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1991
1991
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(3 citation statements)
references
References 11 publications
0
3
0
Order By: Relevance
“…Several products on the list have the potential to serve as intermediates in the preparation of bioactive compounds. One such example is product 11 , which is a derivative of a well-established precursor of (+)-Malyngolide, an antibiotic that exhibits significant activity against Mycobacterium smegmatis and Streptococcus pyogenes . Product 19 , on the other hand, could potentially be used to synthesize Ptaquilosin, a compound that has shown antitumor activity and toxicity toward myelocytic leukemia .…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Several products on the list have the potential to serve as intermediates in the preparation of bioactive compounds. One such example is product 11 , which is a derivative of a well-established precursor of (+)-Malyngolide, an antibiotic that exhibits significant activity against Mycobacterium smegmatis and Streptococcus pyogenes . Product 19 , on the other hand, could potentially be used to synthesize Ptaquilosin, a compound that has shown antitumor activity and toxicity toward myelocytic leukemia .…”
Section: Resultsmentioning
confidence: 99%
“…One such example is product 11, which is a derivative of a well-established precursor of (+)-Malyngolide, an antibiotic that exhibits significant activity against Mycobacterium smegmatis and Streptococcus pyogenes. 25 Product 19, on the other hand, could potentially be used to synthesize Ptaquilosin, a compound that has shown antitumor activity and toxicity toward myelocytic leukemia. 26 In the case of an NHP ester that bears stereocenters at a remote position, the stereochemistry of the amine catalyst, rather than that of the NHP ester, controls the stereochemistry of the coupling product (products 20−23).…”
Section: ■ Introductionmentioning
confidence: 99%
“…The optimal stereochemistry of the β-methyl group will be determined once again by the synthesis and evaluation of both diastereomers. A number of approaches to asymmetric synthesis of 2 have been published since the first report by Mukaiyama in 1980 [18], including the use of chiral auxiliary [19][20][21][22][23][24][25][26][27], chiral pool [28][29][30][31][32][33][34][35][36][37], other asymmetric syntheses [38][39][40] and catalytic asymmetric syntheses [41][42][43][44][45][46][47][48][49].…”
Section: Resultsmentioning
confidence: 99%